Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

190
The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
190
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

202
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
202

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiopoietin-like 4 protects against endothelial dysfunction during bacterial sepsis.

Nature microbiologyĀ·2024
Same author

High-level expression of chromosomally encoded SHV-1 Ī²-lactamase reduces the susceptibility to cefiderocol of clinical isolates of Klebsiella pneumoniae.

The Journal of antimicrobial chemotherapyĀ·2024
Same author

Mycobacterium canettii Tuberculosis Lymphadenopathy in a 3-Year-old Child.

The Pediatric infectious disease journalĀ·2023
Same author

Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis.

Journal of surgical oncologyĀ·2023
Same author

Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2-positive cancers.

Molecular oncologyĀ·2023
Same author

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France.

MicroorganismsĀ·2022
Same journal

Integrating intraspecific trait variation and spatiotemporal variability of selection as levers of action in forest management.

Comptes rendus biologiesĀ·2026
Same journal

[Managing mixed forest standsĀ : bridging the gap between silviculture and ecological theory].

Comptes rendus biologiesĀ·2026
Same journal

[Which forests for which biodiversity under climate change?]

Comptes rendus biologiesĀ·2026
Same journal

[Impacts of climate change on the functioning and productivity of agroecosystems: a focus on the impact of interactions between CO<sub>2</sub>, temperature and water deficit].

Comptes rendus biologiesĀ·2026
Same journal

Autogenic transitions in individuality.

Comptes rendus biologiesĀ·2026
Same journal

Assessing the potential effects of climate change on future forest composition in France.

Comptes rendus biologiesĀ·2026
See all related articles

Related Experiment Video

Updated: Oct 30, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K

Meningococcus, this famous unknown.

Isabel Dos Santos Souza1,2,3, Jason Ziveri2,2,3, Haniaa Bouzinba-Segard2,2,3

  • 1CNRS, UMR8104, Paris, France.

Comptes Rendus Biologies
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Neisseria meningitidis causes meningitis and purpura fulminans. Advances in antimicrobial therapy, vaccines, and understanding host interactions offer new therapeutic strategies for meningococcal infections.

Keywords:
Neisseria meningitidisPathogenesisTherapeutic targetType IV piliVirulence

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.5K
Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

15.1K

Related Experiment Videos

Last Updated: Oct 30, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.5K
Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

15.1K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Immunology

Background:

  • Neisseria meningitidis (meningococcus) is a Gram-negative bacterium.
  • It causes severe invasive diseases like meningitis and purpura fulminans.
  • Historical understanding of meningococcal disease has evolved significantly.

Purpose of the Study:

  • To review the scientific knowledge of meningococcal infections.
  • To highlight advances in disease management and understanding of host-pathogen interactions.
  • To explore emerging therapeutic approaches for meningococcal diseases.

Main Methods:

  • Literature review of historical and recent scientific findings.
  • Analysis of advancements in antimicrobial therapy and vaccine development.
  • Examination of research on meningococcal-host interactions.

Main Results:

  • Significant progress in managing meningococcal infections through antibiotics and vaccines.
  • Accumulated knowledge on bacterial interaction with the human host.
  • Identification of key processes in disease progression.

Conclusions:

  • Antimicrobial therapy and vaccines have greatly improved meningococcal disease management.
  • Understanding host-pathogen interactions reveals new therapeutic targets.
  • Ongoing research promises novel strategies against invasive meningococcal disease.